Interleukin-7 receptor α-chain haplotypes differentially affect soluble IL-7 receptor and IL-7 serum concentrations in children with type 1 diabetes

Pediatric Diabetes
Julia SeyfarthMarc Jacobsen

Abstract

Interleukin-7 receptor α-chain (IL7RA) haplotypes are associated with susceptibility for development of autoimmune diseases, including type 1 diabetes (T1D). A protective IL7RA haplotype which causes lower soluble IL-7R (sIL-7R) serum levels is hypothesized to restrict IL-7-availability for self-reactive T cells. Functional mechanisms affected by a risk-associated IL7RA haplotype are unknown. We investigated the influence of IL7RA haplotypes (tagged by rs6897932T for the protective or by rs1494555G for the risk haplotype) on sIL-7R and IL-7 serum concentrations as well as disease manifestation of children with T1D (n = 259). Possible effects of differential IL-7 serum concentrations on IL-7-mediated in vitro T cell functions (i.e. IL-7R regulation and cytokine expression) were measured in a second study group of children with T1D (n = 42). We detected lower sIL-7R serum concentrations in children with T1D carrying protective or risk haplotypes as compared to reference haplotypes. sIL-7R levels were lowest in T1D children with the protective haplotype and lower IL-7 serum levels were exclusively detected in this study group. We found no evidence for dependency between IL-7 and sIL-7R serum concentrations and no association with ...Continue Reading

References

May 21, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Terry J Fry, Crystal L Mackall
Jan 30, 2007·Nature Reviews. Immunology·Renata Mazzucchelli, Scott K Durum
Feb 3, 2007·Bioinformatics·Juan R GonzálezVíctor Moreno
Jul 31, 2007·Nature Genetics·Simon G GregoryUNKNOWN Multiple Sclerosis Genetics Group
Feb 22, 2008·Proceedings of the National Academy of Sciences of the United States of America·Thomas CalzasciaTak W Mak
Sep 12, 2009·Tissue Antigens·C O'DohertyK Vandenbroeck
Nov 13, 2009·PloS One·Renata I MazzucchelliScott K Durum
Jan 26, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Edwin HoeDavid R Booth
Mar 2, 2010·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Edwin HoeDavid Booth
Oct 29, 2010·Nature·Gonçalo R AbecasisGil A McVean
Mar 14, 2012·Seminars in Immunology·Wangko LundströmCrystal L Mackall
Mar 20, 2012·Seminars in Immunology·Renata I MazzucchelliScott K Durum
Jun 27, 2012·Proceedings of the National Academy of Sciences of the United States of America·Cristina PenarandaHans Dooms
Jan 18, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Pratima DeshpandeJörg J Goronzy
Apr 24, 2013·Proceedings of the National Academy of Sciences of the United States of America·Wangko LundströmCrystal L Mackall
Jul 9, 2013·Journal of Autoimmunity·Hans Dooms
Mar 1, 2014·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Shipra GuptaS Alice Long
Dec 24, 2014·Arthritis Research & Therapy·Sarah M ChurchmanFrederique Ponchel
Feb 10, 2017·Scientific Reports·Hans Jakob HartlingSusanne Dam Nielsen
Apr 6, 2017·Immunology and Cell Biology·Julia SeyfarthMarc Jacobsen

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.